Andere Sprachen Microbot Medical Inc.

Aktien

A2N5AS

US59503A2042

MBOT

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 01.05.2024			% 5 Tage	% 1. Jan.
0,96 ^USD	+4,07 %		+9,10 %	-41,46 %

29.04.	Microbot Medical gibt positive Ergebnisse der ersten Phase der Zusammenarbeit mit Corewell Health bekannt	CI
16.04.	MICROBOT MEDICAL INC. : erhält Kaufen-Rating von HC Wainwright	ZM

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Microbot Medical Announces Positive Results from the First Phase of its Collaboration with Corewell Health™	29.04.
Microbot Medical Announces Positive Results from the First Phase of Its Collaboration with Corewell Health	29.04.
Microbot Medical Shares Status Following Recent Geopolitical Events	15.04.
Microbot Medical Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	27.03.
Microbot Medical Submits US FDA Application to Start Human Clinical Trial for Robotic Surgical System	05.02.
Microbot Medical Submits an IDE Application to Gain FDA Approval to Commence Its Pivotal Clinical Trial in the US	05.02.
Microbot Medical Submits an IDE Application to Gain FDA Approval to Commence Its Pivotal Clinical Trial in the US	05.02.
Microbot Medical Announces Settlement and Release Agreement, Effectively Resolving all Associated Legal Matters	30.01.
Microbot Medical Expands US Clinical Infrastructure in Support of the Upcoming IDE Submission to Commence its First in Human Clinical Study	18.01.
Microbot Medical Expands US Clinical Infrastructure in Support of the Upcoming IDE Submission to Commence its First in Human Clinical Study	18.01.
Microbot Medical Expands US Clinical Infrastructure in Support of the Upcoming IDE Submission to Commence its First in Human Clinical Study	18.01.
Sector Update: Health Care Stocks Ease Friday Afternoon	29.12.
Microbot Medical to Exercise Outstanding Preferred Investment Options for $2.7 Million	29.12.
Microbot Medical Announces Exercise of Outstanding Preferred Investment Options for $2.73 Million in Gross Proceeds Priced At-the-Market Under Nasdaq Rules	29.12.
Sector Update: Health Care Stocks Rise in Late Afternoon	28.12.
Microbot Medical Says GLP Preclinical Study of Liberty Endovascular Robotic Surgical System Met Objectives; Shares Rise	28.12.
Sector Update: Health Care Stocks Advance Thursday Afternoon	28.12.
Microbot Medical Announced Positive Results of Its GLP Pivotal Pre-Clinical Study Where All Study Objectives Were Met	28.12.
Microbot Medical Announces Positive Results of Its GLP Pivotal Pre-Clinical Study Where All Study Objectives Met	28.12.
Microbot Medical Announced Positive Results of Its GLP Pivotal Pre-Clinical Study Where All Study Objectives Were Met	28.12.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Microbot Medical Inc.

Aktien

A2N5AS

US59503A2042

MBOT

Andere Sprachen

Filter